Stocks and Investing
by (remove) : Shawn Egan
RSS • JSON • XML • CSV
Stocks and Investing
by (remove) : Shawn Egan
RSS • JSON • XML • CSV

Shawn Egan Maintained (ARWR) at Hold with Increased Target to $34 on, Feb 7th, 2024


Published on 2024-10-28 08:48:29 - WOPRAI, Shawn Egan
  Print publication without navigation


Shawn Egan of Citigroup, Maintained "Arrowhead Pharmaceuticals, Inc." (ARWR) at Hold with Increased Target from $33 to $34 on, Feb 7th, 2024.

Shawn has made no other calls on ARWR in the last 4 months.



There is 1 other peer that has a rating on ARWR. Out of the 1 peers that are also analyzing ARWR, 0 agree with Shawn's Rating of Hold.



This is the rating of the analyst that currently disagrees with Shawn

  • Jason Gerberry of "B of A Securities" Maintained at Strong Buy with Increased Target to $37 on, Tuesday, January 2nd, 2024
Contributing Sources